These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22974833)
1. Efficient reduction of serum cholesterol by combining a liver-targeted gene delivery system with chemically modified apolipoprotein B siRNA. Kang JH; Tachibana Y; Obika S; Harada-Shiba M; Yamaoka T J Control Release; 2012 Oct; 163(2):119-24. PubMed ID: 22974833 [TBL] [Abstract][Full Text] [Related]
2. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier. Kang JH; Tachibana Y; Kamata W; Mahara A; Harada-Shiba M; Yamaoka T Bioorg Med Chem; 2010 Jun; 18(11):3946-50. PubMed ID: 20472444 [TBL] [Abstract][Full Text] [Related]
3. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Wang J; Dou B; Bao Y Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238 [TBL] [Abstract][Full Text] [Related]
4. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232 [TBL] [Abstract][Full Text] [Related]
5. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Park K; Lee MY; Kim KS; Hahn SK Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167 [TBL] [Abstract][Full Text] [Related]
6. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990 [TBL] [Abstract][Full Text] [Related]
7. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451 [TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615 [TBL] [Abstract][Full Text] [Related]
9. Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency. Rekha MR; Sharma CP Acta Biomater; 2011 Jan; 7(1):370-9. PubMed ID: 20659595 [TBL] [Abstract][Full Text] [Related]
10. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
11. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908 [TBL] [Abstract][Full Text] [Related]
12. Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice. Lee H; Kim SI; Shin D; Yoon Y; Choi TH; Cheon GJ; Kim M Biochem Biophys Res Commun; 2009 Jan; 378(2):192-6. PubMed ID: 19017527 [TBL] [Abstract][Full Text] [Related]
13. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582 [TBL] [Abstract][Full Text] [Related]
14. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine. Shim MS; Kwon YJ Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606 [TBL] [Abstract][Full Text] [Related]
15. Appreciation of concentration of lipoproteins and apolipoproteins in serum of male rats under the influence of diet change composition and its supplementation with group B vitamins. Goluch-Koniuszy Z; Wierzbicka A Acta Sci Pol Technol Aliment; 2011; 10(1):113-21. PubMed ID: 22232533 [TBL] [Abstract][Full Text] [Related]
16. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine-modified PEI: a novel and highly efficient vector for siRNA delivery in mammalian cells. Creusat G; Zuber G Nucleic Acids Symp Ser (Oxf); 2008; (52):91-2. PubMed ID: 18776268 [TBL] [Abstract][Full Text] [Related]
18. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat. Venkatesan N; Devaraj SN; Devaraj H Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407 [TBL] [Abstract][Full Text] [Related]
19. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Jiang G; Park K; Kim J; Kim KS; Hahn SK Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144 [TBL] [Abstract][Full Text] [Related]
20. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo. Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]